ISSN: 0443-511
e-ISSN: 2448-5667
Usuario/a
Idioma
Herramientas del artículo
Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión)
Tamaño de fuente

Open Journal Systems

Prevalencia de Chlamydia trachomatis en mujeres del Hospital General de Zona No. 29 / Chlamydia trachomatis prevalence in women from the Hospital General de Zona No. 29

Marcos Ramses Escobedo-Guerra, Marcela López-Hurtado, Rodrigo Gutiérrez-Trujillo, Fernando Martín Guerra-Infante

Resumen


Resumen

Introducción: la Chlamydia trachomatis es la principal causa de infecciones bacterianas de transmisión sexual a nivel mundial. Se estima que cada año se producen 131 millones de casos. Cursa de manera asintomática, pero la infección ascendente en mujeres puede conducir a la enfermedad inflamatoria pélvica, embarazo ectópico e infertilidad. 
Objetivo: determinar la prevalencia de C. trachomatis en mujeres de población abierta que acuden al Hospital General de Zona No. 29.
Material y métodos: se realizó la identificación de C. trachomatis por pruebas de PCR a 200 muestras de exudado vaginal y se determinó su genotipo. Paralelamente, se realizó el diagnóstico microbiológico de rutina.
Resultados: la prevalencia de C. trachomatis fue del 8.5% (17/200) con una concomitancia significativa de p = 0.006 con Gardnerella vaginalis (riesgo relativo de 2.871, IC95%: 1.574-5.236). Asimismo, se identificó C. trachomatis en cinco muestras como el único agente etiológico. Dieciséis cepas de C. trachomatis pertenecieron al genotipo F. Una cepa identificada de C. trachomatis presentó motivos genéticos similares a la variante mexicana reportada en 2019.
Conclusiones: la prevalencia de C. trachomatis en la población estudiada nos indica la necesidad de implementar técnicas de diagnóstico para esta bacteria. El uso de la PCR permite realizar una determinación genotípica rápida, que explicaría el comportamiento epidemiológico de la C. trachomatis y representaría una mejora significativa de la calidad de vida de la paciente.

 

Abstract

Background: Chlamydia trachomatis is the main cause of sexually transmitted bacterial infections worldwide. An estimated of 131 million cases occur each year. It is asymptomatic, but ascending infection in women can lead to pelvic inflammatory disease, ectopic pregnancy, and infertility.

Objective: To determine the prevalence of C. trachomatis in open population women who attend the Hospital General de Zona No. 29.

Material and methods: Identification of C. trachomatis was carried out by PCR testing of 200 vaginal exudate samples and its genotype was determined. In parallel, a routine microbiological diagnosis was carried out.

Results: The prevalence of C. trachomatis was 8.5% (17/200) with a significant concomitance of p = 0.006 with Gardnerella vaginalis (relative risk of 2.871, 95%CI: 1.574- 5.236). Likewise, C. trachomatis was identified in 5 samples as the only etiological agent. Sixteen strains of C. trachomatis belong to genotype F. An identified strain of C. trachomatis presented genetic motifs similar to the Mexican variant reported in 2019.

Conclusions: The prevalence of C. trachomatis in the studied population indicates the need to implement diagnostic techniques for this bacterium. The use of PCR allows a rapid genotypic determination that would explain the epidemiological behavior of C. trachomatis and would represent a significant improvement in the quality of life of the patient. 

 


Palabras clave


Chlamydia trachomatis; Enfermedades de Transmisión Sexual; Reacción en Cadena de la Polimerasa; Genotipo / Chlamydia trachomatis; Sexually Transmitted Diseases; Polymerase Chain Reaction; Genotype

Texto completo:

PDF

Referencias


 

Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304. Disponible en: http://doi.org/10.1371/journal.pone.0143304.

 

Workowski KA, Stevens CE, Suchland RJ, Holmes KK, Eschenbach DA, Pettinger MB, et al. Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar. Clin Infect Dis. 1994;19:756-60. doi: 10.1001/jama.285.1.47.

 

Elwell C, Mirrashidi K, Engel J. Chlamydia cell biology and pathogenesis. Nature Reviews Microbiology. 2016;14:385-400. doi: 10.1038/nrmicro.2016.30.

 

Welsh LE, Quinn TC, Gaydos CA. Influence of endocervical specimen adequacy on PCR and direct fluorescent-antibody staining for detection of Chlamydia trachomatis infections. J Clin Microbiol. 1997;35(12):3078-81. Disponible en: https://doi:10.1128/JCM.35.12.3078-3081.1997. 

 

Yeow TC, Wong WF, Sabet NS, Sulaiman S, Shahhosseini F, Tan GM, et al. Prevalence of plasmid-bearing and plasmid-free Chlamydia trachomatis infection among women who visited obstetrics and gynecology clinics in Malaysia. BMC Microbiol. 2016;16:45. doi: 10.1186/s12866-016-0701-z.

 

Guerra-Infante F, Flores-Medina S, Arteaga-Troncoso G, Zamora-Ruiz A, López-Hurtado M, Ortiz-Ibarra FJ. Risk factors and reproductive sequelae associated with Chlamydia trachomatis infection in infertile women. Salud Pública Mex. 2003;45:672-80.

 

Papp JR, Schachter J, Gaydos CA, Van der Pol B. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae-2014. MMWR Recomm Rep. 2014;63:1-19.

 

Mahony JB, Luinstra KE, Sellors JW, Jang D, Chernesky MA. Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in first void urine from asymptomatic and symptomatic men. J Clin Microbiol. 1992;30:2241-45. doi: 10.1128/JCM.30.9.2241-2245.1992.

 

Escobedo-Guerra MR, Katoku-Herrera M, Lopez-Hurtado M, Villagrana-Zesati JR, de Haro-Cruz MJ, Guerra-Infante FM. Identification of a new variant of Chlamydia trachomatis in Mexico. Enferm Infecc Microbiol Clin. 2019;37(2):93-9. doi: 10.1016/j.eimce.2018.02.024.

 

Yang CL, Maclean I, Brunham RC. DNA sequence polymorphism of the Chlamydia trachomatis omp1 Gene. J Infect Dis. 1993;168:1225-30. doi: 10.1093/infdis/168.5.1225.

 

Zhang Z, Schwartz S, Wagner L, Miller W. A greedy algorithm for aligning DNA sequences. J Comput Biol. 2000;7:203-14. doi: 10.1089/10665270050081478.

 

Morgulis A, Coulouris G, Raytselis Y, Madden TL, Agarwala R, Schäffer AA. Database indexing for production MegaBLAST searches. Bioinformatics. 2008;24:1757-64. doi: 10.1093/bioinformatics/btn322.

 

Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties, and weight matrix choice. Nucleic Acids Res. 1994;22:4673-80. doi: 10.1093/nar/22.22.4673.

 

Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 1988;16:10881-90. doi: 10.1093/nar/16.22.10881.

 

Molenaar MC, Singer M, Ouburg S. The two-sided role of the vaginal microbiome in Chlamydia trachomatis and Mycoplasma genitalium pathogenesis. J Reprod Immunol. 2018;130:11-17. doi: 10.1016/j.jri.2018.08.006.

 

Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health external icon. Sex Transm Dis. 2007;34(11):864-9. doi: 10.1097/OLQ.0b013e318074e565.

 

Adachi K, Nielsen-Saines K, Klausner JD. Chlamydia trachomatis infection in pregnancy: the global challenge of preventing adverse pregnancy and infant outcomes in sub-Saharan Africa and Asia. Biomed Res Int. 2016;2016:9315757. doi: 10.1155/2016/9315757.

 

Vajdic CM, Middleton M, Bowden FJ, Fairley CK, Kaldor JM. The prevalence of genital Chlamydia trachomatis in Australia 1997–2004: a systematic review. Sex Health. 2005;2(3):169-83. doi: 10.1071/SH05018.

 

Wilson J, Honey E, Templeton A, Paavonen J, Mårdh P-A, Stary A, et al. A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update. 2002;8(4):385-94. doi: 10.1093/humupd/8.4.385

 

Scholes D, Satterwhite CL, Yu O, Fine D, Weinstock H, Berman S. Long-term trends in Chlamydia trachomatis infections and related outcomes in a US managed care population. Sex Transm Dis. 2012;39(2):81-8. doi: 10.1097/OLQ.0b013e31823e3009.

 

Lleo MM, Ghidini V, Tafi MC, Castellani F, Trento I, Boaretti M. Detecting the presence of bacterial DNA by PCR can be useful in diagnosing culture-negative cases of infection, especially in patients with suspected infection and antibiotic therapy. FEMS Microbiology Letters. 2014;354(2):153-60. doi: 10.1111/1574-6968.12422.

 

Mancini N, Carletti S, Ghidoli N, Cichero P, Burioni R, Clementi M. The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev. 2010;23(1):235-51. doi: 10.1128/CMR.00043-09.

 

Nii-Trebi NI. Emerging and neglected infectious diseases: Insights, advances, and challenges. BioMed Research International. 2017;2017:1-15. doi: 10.1155/2017/5245021.

 

De Haro-Cruz MJ, Deleón-Rodriguez I, Escobedo-Guerra MR, López-Hurtado M, Arteaga-Troncoso G, Ortiz-Ibarra FJ, et al. Genotyping of Chlamydia trachomatis from endocervical specimens of infertile Mexican women. Enferm Infecc Microbiol Clin. 2011;29(2):102-8. doi: 10.1016/j.eimc.2010.08.014.

 

Casillas-Vega N, Morfín-Otero R, García S, Llaca-Díaz J, Rodríguez-Noriega E, Camacho-Ortiz A, et al. Frequency and genotypes of Chlamydia trachomatis in patients attending the obstetrics and gynecology clinics in Jalisco, Mexico and correlation with sociodemographic, behavioral, and biological factors. BMC Womens Health. 2017;17(1):83. doi: 10.1186/s12905-017-0428-5.

 

López-Hurtado M, Escarcega-Tame MA, Escobedo-Guerra MR, de Haro-Cruz MJ, Guerra-Infante FM. Identification of Chlamydia trachomatis genotypes in Mexican men with infertile women as sexual partners. Enferm Infecc Microbiol Clin. 2021;S0213-005X(21)00043-4. doi: 10.1016/j.eimc.2021.02.005.

 

Carlson JH, Whitmire WM, Crane DD, Wicke L, Virtaneva K, Sturdevant DE, et al. The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Infect Immun. 2008;76:2273-83. doi: 10.1128/iai.00102-08.

 

Gong S. Yang Z, Lei L, Shen L, Zhong G. Characterization of Chlamydia trachomatis plasmid-encoded open reading frames. J Bacteriol. 2013;195:3819-26. doi: 10.1128/JB.00511-13.

 

Tamarelle J, de Barbeyrac B, Le Hen I, Thiébaut A, Bébéar C, Ravel J, et al. Vaginal microbiota composition and association with prevalent Chlamydia trachomatis infection: A crosssectional study of young women attending a STI clinic in France. Sex Transm Infect. 2018;94(8):616-18. doi: 10.1136/sextrans-2017-053346.

 

Gallo MF, Macaluso M, Warner L, Fleenor ME, Hook EW, Brill I, et al. Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links. Ann Epidemiol. 2012;22:213-220. doi: 10.1016/j.annepidem.2011.11.005.

 


Enlaces refback

  • No hay ningún enlace refback.